Cargando…

The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma

Detalles Bibliográficos
Autores principales: Ham, J S, Kim, S J, Choi, J Y, Hyun, S H, Choi, S-K, Kim, H S, Lim, S H, Lee, J Y, Jung, S-H, Ko, Y H, Kim, W S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771965/
https://www.ncbi.nlm.nih.gov/pubmed/26871713
http://dx.doi.org/10.1038/bcj.2016.2
_version_ 1782418477626163200
author Ham, J S
Kim, S J
Choi, J Y
Hyun, S H
Choi, S-K
Kim, H S
Lim, S H
Lee, J Y
Jung, S-H
Ko, Y H
Kim, W S
author_facet Ham, J S
Kim, S J
Choi, J Y
Hyun, S H
Choi, S-K
Kim, H S
Lim, S H
Lee, J Y
Jung, S-H
Ko, Y H
Kim, W S
author_sort Ham, J S
collection PubMed
description
format Online
Article
Text
id pubmed-4771965
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47719652016-03-09 The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma Ham, J S Kim, S J Choi, J Y Hyun, S H Choi, S-K Kim, H S Lim, S H Lee, J Y Jung, S-H Ko, Y H Kim, W S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-02 2016-02-12 /pmc/articles/PMC4771965/ /pubmed/26871713 http://dx.doi.org/10.1038/bcj.2016.2 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Ham, J S
Kim, S J
Choi, J Y
Hyun, S H
Choi, S-K
Kim, H S
Lim, S H
Lee, J Y
Jung, S-H
Ko, Y H
Kim, W S
The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title_full The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title_fullStr The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title_full_unstemmed The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title_short The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
title_sort prognostic value of interim and end-of-treatment pet/ct in patients with newly diagnosed peripheral t-cell lymphoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771965/
https://www.ncbi.nlm.nih.gov/pubmed/26871713
http://dx.doi.org/10.1038/bcj.2016.2
work_keys_str_mv AT hamjs theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimsj theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT choijy theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT hyunsh theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT choisk theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimhs theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT limsh theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT leejy theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT jungsh theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT koyh theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimws theprognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT hamjs prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimsj prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT choijy prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT hyunsh prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT choisk prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimhs prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT limsh prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT leejy prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT jungsh prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT koyh prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma
AT kimws prognosticvalueofinterimandendoftreatmentpetctinpatientswithnewlydiagnosedperipheraltcelllymphoma